Last reviewed · How we verify

NCT03847948: START

Biological Factors Associated With Subclinical Valvular Thrombosis

Status unknown Last updated 29 October 2021
What this trial tests

trial in Aortic Stenosis in 166 participants. Status unknown.

Timeline
1 June 2018
Primary endpoint
31 December 2021
31 March 2022

Quick facts

Lead sponsorHospital San Carlos, Madrid
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment166
Start date1 June 2018
Primary completion31 December 2021
Estimated completion31 March 2022
Sites2 locations across Spain

Conditions studied

Sponsor

Hospital San Carlos, Madrid

Who can join

18 and older, any sex, with Aortic Stenosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A prospective, multicentric cohort study including 166 patients with symptomatic aortic stenosis treated with transcatheter aortic valve implantation (TAVI). \- The main objective is to determine whether the high residual platelet reactivity rates in patients undergoing TAVI is associated with the occurrence of clinical and / or subclinical prosthetic valve thrombosis measured by echocardiography and multi-slice computerized tomography

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Aortic Stenosis

Currently open trials in the same condition.

Other Hospital San Carlos, Madrid trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03847948.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing